Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative pain after primary teeth pulpectomy with dexamethasone final intracanal irrigation
IRCT20260413069072N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexamethasone in pulpal necrosis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Postoperative pain intensity at 6 hours, Postoperative pain intensity at 12 hours and 4 more. Started Apr 2026; status: completed.
02
Drugs
dexamethasone
03
Conditions
pulpal necrosis
Beyond the preview
Go deeper on IRCT20260413069072N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260413069072N1.